A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity AT Huang, B Garcia-Carreras, MDT Hitchings, B Yang, LC Katzelnick, ... Nature communications 11 (1), 4704, 2020 | 1101 | 2020 |
Assessing the global threat from Zika virus J Lessler, LH Chaisson, LM Kucirka, Q Bi, K Grantz, H Salje, AC Carcelen, ... Science 353 (6300), aaf8160, 2016 | 452 | 2016 |
Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region I Rodriguez-Barraquer, F Costa, EJM Nascimento, N Nery, PMS Castanha, ... Science 363 (6427), 607-610, 2019 | 278 | 2019 |
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment NM Ferguson, I Rodríguez-Barraquer, I Dorigatti, L Mier-y-Teran-Romero, ... Science 353 (6303), 1033-1036, 2016 | 278 | 2016 |
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk H Salje, DAT Cummings, I Rodriguez-Barraquer, LC Katzelnick, J Lessler, ... Nature 557 (7707), 719-723, 2018 | 256 | 2018 |
The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ... PLoS medicine 13 (11), e1002181, 2016 | 213 | 2016 |
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave ST Tan, AT Kwan, I Rodríguez-Barraquer, BJ Singer, HJ Park, ... Nature Medicine 29 (2), 358-365, 2023 | 211 | 2023 |
Mapping global variation in dengue transmission intensity L Cattarino, I Rodriguez-Barraquer, N Imai, DAT Cummings, ... Science translational medicine 12 (528), eaax4144, 2020 | 211 | 2020 |
From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil I Rodriguez-Barraquer, MT Cordeiro, C Braga, WV de Souza, ET Marques, ... PLoS neglected tropical diseases 5 (1), e935, 2011 | 193 | 2011 |
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms MJ Peluso, AN Deitchman, L Torres, NS Iyer, SE Munter, CC Nixon, ... Cell Reports 36 (6), 2021 | 190 | 2021 |
Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations B Sun, N Tang, MJ Peluso, NS Iyer, L Torres, JL Donatelli, SE Munter, ... Cells 10 (2), 386, 2021 | 182 | 2021 |
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward JE Bryant, AS Azman, MJ Ferrari, BF Arnold, MF Boni, Y Boum, K Hayford, ... Science immunology 5 (47), eabc6347, 2020 | 167 | 2020 |
Enhancing disease surveillance with novel data streams: challenges and opportunities BM Althouse, SV Scarpino, LA Meyers, JW Ayers, M Bargsten, ... EPJ data science 4 (1), 1-8, 2015 | 162 | 2015 |
Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure I Rodriguez-Barraquer, E Arinaitwe, P Jagannathan, MR Kamya, ... Elife 7, e35832, 2018 | 147 | 2018 |
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay MJ Peluso, S Takahashi, J Hakim, JD Kelly, L Torres, NS Iyer, K Turcios, ... Science advances 7 (31), eabh3409, 2021 | 141 | 2021 |
Unraveling the drivers of MERS-CoV transmission S Cauchemez, P Nouvellet, A Cori, T Jombart, T Garske, H Clapham, ... Proceedings of the national academy of sciences 113 (32), 9081-9086, 2016 | 127 | 2016 |
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study C Andolina, JC Rek, J Briggs, J Okoth, A Musiime, J Ramjith, N Teyssier, ... The Lancet Infectious Diseases 21 (11), 1568-1578, 2021 | 122 | 2021 |
Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children LC Rubiano, MIC Miranda, S Muvdi Arenas, LM Montero, ... Journal of Infectious Diseases 205 (4), 684-692, 2012 | 119 | 2012 |
Long-term circulation of Zika virus in Thailand: an observational study K Ruchusatsawat, P Wongjaroen, A Posanacharoen, ... The Lancet Infectious Diseases 19 (4), 439-446, 2019 | 115 | 2019 |
Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus LC Katzelnick, A Coello Escoto, BD McElvany, C Chávez, H Salje, W Luo, ... PLoS neglected tropical diseases 12 (10), e0006862, 2018 | 100 | 2018 |